The status of the corticotropin releasing factor (CRF)

Neuroendocrinology
|January 1, 1977
PubMed

Insights

Early research suggested multiple factors release adrenocorticotropic hormone (ACTH). This review revisits the evidence for various ACTH-releasing agents, challenging the long-held neurohumoral theory of a single hypothalamic controller.

Area of Science:

  • Endocrinology
  • Neuroendocrinology
  • Physiology

Background:

  • Historical research on adrenocorticotropic hormone (ACTH) release indicated multiple influencing factors.
  • The neurohumoral theory proposed a unique hypothalamic agent for each pituitary hormone, guiding ACTH research for two decades.
  • A singular focus on identifying a unique ACTH-releasing hormone dominated early studies.

Purpose of the Study:

  • To re-examine the scientific evidence supporting the release of ACTH by multiple factors.
  • To challenge the established neurohumoral theory's premise of a single hypothalamic controlling agent for ACTH.
  • To provide a comprehensive review of the historical and current perspectives on ACTH regulation.

Main Methods:

  • Literature review of early and contemporary studies on ACTH release.
  • Analysis of historical data and theoretical frameworks in neuroendocrinology.
  • Synthesis of evidence regarding the multiplicity of factors influencing ACTH secretion.

Main Results:

  • Evidence suggests that ACTH release is not solely regulated by a single hypothalamic factor.
  • The historical search for a unique ACTH-releasing hormone may have overlooked the complexity of the system.
  • Multiple hypothalamic and extra-hypothalamic factors likely contribute to ACTH regulation.

Conclusions:

  • The regulation of ACTH release is more complex than previously assumed by the singular neurohumoral theory.
  • Revisiting the evidence supports the hypothesis of multiple factors controlling ACTH secretion.
  • Future research should focus on elucidating the interplay of various agents in ACTH regulation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...